Author:
Faruk Kose Mehmet,Karabuk Emine
Reference37 articles.
1. Munoz N, Bosch FX, Castellsague X, Díaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer. 2004;111(2):278-285
2. Usubütün A, Alemany L, Kucukali T, Ayhan A, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. International Journal of Gynecological Pathology. 2009;28(6):541-548
3. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24(Suppl 3):S3/11-S3/25
4. Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papilloma-virus infection and lung cancer: A system review and meta-analysis. Oncotarget. 2017;8(56):96419-96432
5. Ozgul N, Tuncer M, Abacioglu M, Gultekin M. Estimating prevalence of genital warts in Turkey: Survey among KETEM-affiliated gynecologists across Turkey. Asian Pacific Journal of Cancer Prevention. 2011;12(9):2397-2400